SEC Comment Letter for KAZIA THERAPEUTICS LTD (KZIA) (CIK 0001075880) (KZIA) — Mar 29, 2013
KAZIA THERAPEUTICS LTD (KZIA) (CIK 0001075880)
Date: March 29, 2013 · CIK: 0001075880 · Accession: 0000000000-13-017004
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 000-29962
Letter
March 29, 201 3 Via E -mail Graham Kelly Chief Executive Officer Novogen Limited 1-7 Waterloo Road, Level 1 North Ryde, New South Wales 2113 Australia
Re: Novogen Limited Form 20-F for the Fiscal Year Ended June 30, 201 2 Filed Octob er 29, 201 2 File No. 000-29962
Dear Dr. Kelly :
We have reviewed your March 7 , 201 3 response to our February 14 , 201 3 letter and have the following comment .
Please respond to this letter within 10 business days by amending your filing or by advising us when you will provide the requested response. Please furnish us a letter on EDGAR under the form type label CORRESP that key s your response to our comment.
After reviewin g any amendment to your filing and information you provide in respon se to this comment, we may have additional comments.
Report of Independent Registered Public Accounting Firm , page 75
1. Please refer to your response to our prior comment. If Grant Thornton is assuming responsibility for all periods presented , no reference should be made in its report to the prior auditor. Therefore, please amend your filing to include a revised audit rep ort from Grant Thornton Audit Pty Ltd that removes the reference to the prior auditor.
You may contact Vanessa Robertson, Staff Accountant, at (202) 551 -3649 or Lisa Vanjoske, Assistant Chief Accountant, at (202) 551 -3614 if you have any questions regar ding the comment. In this regard, do not hesitate to contact me at (202) 551 -3679 .
Sincerely,
/s/ Jim B. Rosenberg
Show Raw Text
March 29, 201 3 Via E -mail Graham Kelly Chief Executive Officer Novogen Limited 1-7 Waterloo Road, Level 1 North Ryde, New South Wales 2113 Australia Re: Novogen Limited Form 20-F for the Fiscal Year Ended June 30, 201 2 Filed Octob er 29, 201 2 File No. 000-29962 Dear Dr. Kelly : We have reviewed your March 7 , 201 3 response to our February 14 , 201 3 letter and have the following comment . Please respond to this letter within 10 business days by amending your filing or by advising us when you will provide the requested response. Please furnish us a letter on EDGAR under the form type label CORRESP that key s your response to our comment. After reviewin g any amendment to your filing and information you provide in respon se to this comment, we may have additional comments. Report of Independent Registered Public Accounting Firm , page 75 1. Please refer to your response to our prior comment. If Grant Thornton is assuming responsibility for all periods presented , no reference should be made in its report to the prior auditor. Therefore, please amend your filing to include a revised audit rep ort from Grant Thornton Audit Pty Ltd that removes the reference to the prior auditor. You may contact Vanessa Robertson, Staff Accountant, at (202) 551 -3649 or Lisa Vanjoske, Assistant Chief Accountant, at (202) 551 -3614 if you have any questions regar ding the comment. In this regard, do not hesitate to contact me at (202) 551 -3679 . Sincerely, /s/ Jim B. Rosenberg Jim B. Rosenberg Senior Assistant Chief Accountant